This was when Heather's mutant powers first manifested. Her mutation allows her to gain whatever power she needs to save ...

Significant weight gain was observed in ponsegromab-treated groups compared to placebo, with improvements in appetite and ...

Edward White has given his Buy rating due to a combination of factors related to Chimerix’s promising developments in their treatment for H3 K27M-mutant diffuse glioma ... By upgrading to TipRanks ...

This important manuscript provides insights into the competition between Splicing Factor 1 (SF1) and Quaking (QKI) for binding at the ACUAA branch point sequence in a model intron, regulating exon ...

Dordaviprone is being evaluated in the Phase 3 ACTION trial that is currently enrolling H3 K27M-mutant diffuse glioma patients at over 145 sites in 15 countries. Chimerix expects interim OS data in ...

Good day, everyone, and welcome to the Syndax Third Quarter 2024 Earnings Conference Call. Today's call is being recorded. All participants have been placed in a listen-only mode. You'll have an ...

Available in standard white or in limited edition black, the latter with a Turbo mode featuring NOS Germanium 1n34a diodes, ...

Warning: Contains SPOILERS for Negasonic Teenage Warhead #1! Marvel fans are assuredly the most familiar with Negasonic ...

Agios Pharmaceuticals, Inc. AGIO reported earnings of $16.22 per share for the third quarter of 2024, which missed the Zacks Consensus Estimate of $16.69. In the year-ago quarter, the company had ...

The top stories in non-small cell lung cancer (NSCLC) for 2024 included practice-changing results in EGFR-mutant disease, an ...

"As you lose weight, your body's caloric needs will change. So if you've noticed a lack of progress or weight gain after consistent weight loss, not readjusting your nutrition may be the culprit," ...